Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (8): 736-740.doi: 10.3736/jcim20090806

• Original Clinical Research • Previous Articles     Next Articles

Effects of oxymatrine on microinflammatory state in patients undergoing continuous hemodialysis: A randomized controlled trial

 Wen-xiang Zhou,Wen-bin Zheng, Xiao-mei Huang, Ying Zhang, Xiang-zhi Nie, Hong-bing Li, Da He, Lan-qian Xie   

  1. Department of Nephrology, Wuhan No. 1 Hospital, Wuhan 430022, Hubei Province, China
  • Received:2009-02-27 Accepted:2009-06-03 Online:2009-08-20 Published:2009-08-15
  • Contact: Wen-xiang Zhou


Chronic microinflammatory state is common in the patients undergoing maintenance hemodialysis (MHD), which seriously affects the long-term survival rate of MHD patients. It is important to improve the microinflammatory state in MHD patients.

To investigate the effects of oxymatrine on microinflammatory state in patients undergoing continuous hemodialysis.Design, setting, participants and interventions: Sixty MHD patients in Blood Purification Center, Wuhan No.1 Hospital, from June to September 2008, were randomized into treatment group (30 cases) and control group (30 cases). Oxymatrine Capsule was orally administered to the patients in the treatment group 0.4 g once a day for 3 months, while the patients in the control group were not given oxymatrine. Main outcome measures: The serum concentrations of high-sensitivity C-reactive protein (hs-CRP), interleukin-1β(IL-1β), tumor necrosis factor-α (TNF-α), albumin (Alb), pre-albumin (PAB), total cholesterol (TC) and triglyceride (TG) were detected before and after 3-month treatment.

Three patients in the treatment group had a stomachache on the first day of treatment, and two out of the three quitted the trial. The stomachache disappeared in one patient after stopping taking the drug, and did not recur after continuing to receive the intervention. Two patients in the treatment group had skin rash with pruritus on the second day of treatment. The rash disappeared after the patients stopped taking the drug, and did not recur after continuing to receive the intervention. A total of 58 cases accessed to the statistical analysis, while 2 cases were excluded. In the treatment group, the concentrations of hs-CRP, IL-1β and TNF-α significantly decreased (P<0.01) and the mean values of Alb, PAB, TC and TG significantly increased after the treatment as compared with those before the treatment (P<0.01), but there were no significant differences in all parameters between before and after treatment in the control group. There were significant differences in all parameters between the treatment group and the control group after treatment (P<0.01, P<0.05).

Oxymatrine can improve the microinflammatory state in the patients undergoing continuous hemodialysis.

Key words: Oxymatrine, Hemodialysis, Inflammation, Randomized controlled trial

Figure 1

Flow diagram of this randomized trial "

Table 1

General data in two groups"

Item Control group (n=30) Treatment group (n=28)
Age ($\bar{x}$±s, years) 44.27±16.19 48.06±12.47
Sex (male/female) 17/13 15/13
Duration of hemodialysis ($\bar{x}$±s, months) 53.4±14.9 56.7±21.8
Primary disease
Chronic glomerulonephritis 21 19
Diabetic nephropathy 4 3
Hypertension 3 4
Polycystic kidney disease 0 1
Unknown 2 1

Table 2

Changes of biochemical parameters in two groups ($\bar{x}$±s)"

Group n Alb (g/L) PAB (g/L) TC (mmol/L) TG (mmol/L)
Before treatment 30 37.13±2.41 0.29±0.04 3.89±0.61 1.46±0.36
After treatment 30 37.95±1.64 0.28±0.05 3.99±0.61 1.48±0.48
Before treatment 28 37.51±2.21 0.29±0.05 3.72±0.46 1.44±0.34
After treatment 28 41.29±1.91**△△ 0.33±0.05**△△ 4.19±0.52** 1.73±0.23**△△

Table 3

Changes of microinflammation indexes in two groups ($\bar{x}$±s)"

Group n hs-CRP (mg/L) IL-1β (pg/L) TNF-α (pg/L)
Before treatment 30 10.56±1.49 33.41±2.83 24.37±1.96
After treatment 30 10.78±1.02 33.95±2.00 24.20±1.59
Before treatment 28 10.27±1.55 33.97±2.30 26.16±1.90
After treatment 28 7.38±1.36**△△ 22.48±1.94**△△ 19.29±1.50**
[1] Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimbürger O, Lindholm B , Bergström J .Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients[J]. J Am Soc Nephrol, 2002,13(1):28-36
[2] Schömig M, Eisenhandt A, Ritz E . The microinflammatory state of uremia[J]. Blood Purif, 2000,18(4):327-332
doi: 10.1159/000014457
[3] Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, Chatzipanagiotou S, Nicolaou C . The variability and accurate assessment of microinflammation in haemodialysis patients[J]. Nephrol Dial Transplant, 2004,19(1):150-157
doi: 10.1093/ndt/gfg486 pmid: 14671050
[4] Wang HY. Nephrology(2nd ed)[M]. Beijing: People’s Medical Publishing House, 1997,( 2nd ed):243-277
王海燕 .肾脏病学(第2版)[M]. 北京: 人民卫生出版社, 1997,( 第2版):243-277
[5] Ramirez R, Carracedo J, Merino A, Nogueras S, Alvarez-Lara MA, Rodríguez M, Martin-Malo A, Tetta C . Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport[J]. Kindey Int, 2007,72(1):108-113
doi: 10.1038/
[6] Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Giovannini L, Palla R, Tetta C . C-reactive protein as a marker of chronic inflammation in uremic patients[J]. Blood Purif, 2000,18(3):183-190
doi: 10.1159/000014417
[7] Zhu HM, Shen X. Clinical laboratory diagnosis[M]. Shanghai: Shanghai Scientific and Technical Publishers, 2004: 579-682
朱汉民, 沈霞 . 临床实验诊断学[M]. 上海: 上海科学技术出版社, 2004: 579-682
[8] Yao Y, Liu HL, Zhang XL . Relationship between inflammation and serum albumin levels in hemodialysis patients[J]. Zhongguo Xue Ye Jing Hua, 2004,3(1):18-20
姚英, 刘惠兰, 张香玲 . 血液透析患者血清白蛋白水平与系统炎症反应的相关关系[J]. 中国血液净化, 2004,3(1):18-20
[9] Kalantar-Zadeh K, Block G , McAllister CJ, Humphreys MH, Kopple JD . Appetite and inflammation, nutration, anemia, and clinical outcome in hemodialysis patients[J]. Am J Clin Nutr, 2004,80(2):299-307
doi: 10.1051/rnd:2004054 pmid: 15277149
[10] Ni SF, Liu H, Sun PW, Ma J, Feng ZG . New progress on pharmacology study of Kushen[J]. Shi Zhen Guo Yi Guo Yao, 2008,19(6):1506-1507
倪士峰, 刘惠, 孙平文, 马洁, 冯志刚 . 苦参药理学研究新进展[J]. 时珍国医国药, 2008,19(6):1506-1507
[11] Yao GL, Liao TT, Zhou L, Li MR, Yuan HZ, Gui BS . Serum MMP-9 and TIMP-1 levels in patients with chronic kidney disease after oxymatrine treatment[J]. Xi’an Jiao Tong Da Xue Xue Bao, 2008,29(1):84-86
姚钢炼, 廖婷婷, 周琳, 李美如, 袁浩峥, 桂保松 . 氧化苦参碱对慢性肾脏病患者血清MMP-9和TIMP-1的影响[J]. 西安交通大学学报, 2008,29(1):84-86
[12] Chen C, Jin Y . Effects of oxymatrine on expression of nuclear factor kappa B in kidneys of rats with adriamycin-induced chronic renal fibrosis[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2007,27(3):345-348
doi: 10.3321/j.issn:1673-4254.2007.03.022
陈晨, 金玉 . 氧化苦参碱对阿霉素大鼠慢性肾纤维化组织中核因子-κB表达的影响[J]. 南方医科大学学报, 2007,27(3):345-348
doi: 10.3321/j.issn:1673-4254.2007.03.022
[13] Chu WJ, Li HJ . The role of OMT on serum TNF-α and IL-10 in rats with acute necrotizing pancreatitis[J]. Zhejiang Lin Chuang Yi Xue, 2005,7(12):903-906
doi: 10.3969/j.issn.1008-7664.2005.12.003
褚卫建, 李海军 . 氧化苦参碱对急性坏死性胰腺炎大鼠血清TNF-α和IL-10的作用[J]. 浙江临床医学, 2005,7(12):903-906
doi: 10.3969/j.issn.1008-7664.2005.12.003
[14] Jiao X, Shen QY, Wang LM, Xu YP . Study on anti-inflammatory of oxymatrine on asthmatic mice[J]. Shanghai Di Er Yi Ke Da Xue Xue Bao, 2002,22(4):303-305
焦霞, 沈其昀, 王利民, 许以平 . 氧化苦参碱对哮喘小鼠抗炎作用的研究[J]. 上海第二医科大学学报, 2002,22(4):303-305
[15] Zheng P, Niu FL, Liu WZ, Shi Y, Lu LG . Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats[J]. World J Gastroenterol, 2005,11(3):4912-4915
doi: 10.1055/s-2005-858479 pmid: 16097071
[16] Huang XM, Li B . Effect of oxymatrine on TNF-α, IL-6 and IL-8 in mice[J]. Zhong Cheng Yao, 2003,25(11):903-906
doi: 10.3969/j.issn.1001-1528.2003.11.015
黄秀梅, 李波 . 氧化苦参碱对TNF-α、IL-6和IL-8的影响[J]. 中成药, 2003,25(11):903-906
doi: 10.3969/j.issn.1001-1528.2003.11.015
[17] Sun YN, Gong SJ, Huang ZQ . Effects of oxymatrine on TNF-α, IL-6 and IL-8 in serum of chronic hepatitis B[J]. Zhongguo Zong He Lin Chuang, 2003,19(10):908-909
孙永年, 龚守军, 黄祝青 . 苦参素对慢性乙型肝炎血清肿瘤坏死因子-α、白细胞介素-6、白细胞介素-8的影响[J]. 中国综合临床, 2003,19(10):908-909
[1] Chiung-Hui Huang, Mei-Ling Yeh, Fang-Pey Chen, Daphne Wu. Low-level laser acupuncture reduces postoperative pain and morphine consumption in older patients with total knee arthroplasty: A randomized placebo-controlled trial. Journal of Integrative Medicine, 2022, 20(4): 321-328.
[2] Keat Lam Ho, Phaik Har Yong, Chee Woon Wang, Umah Rani Kuppusamy, Chek Tung Ngo, Festo Massawe, Zhi Xiang Ng. Peperomia pellucida (L.) Kunth and eye diseases: A review on phytochemistry, pharmacology and toxicology. Journal of Integrative Medicine, 2022, 20(4): 292-304.
[3] Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[4] Ubiratan Cardinalli Adler, Maristela Schiabel Adler, Ana Elisa Madureira Padula, Livia Mitchiguian Hotta, Amarilysde Toledo Cesar, José Nelson Martins Diniz, Helen de Freitas Santos, Edson Zangiacomi Martinez. Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study). Journal of Integrative Medicine, 2022, 20(3): 221-229.
[5] Jia-yi Zhao, Jin Pu, Jian Fan, Xin-yu Feng, Jian-wen Xu, Rong Zhang, Yan Shang. Tanshinone IIA prevents acute lung injury by regulating macrophage polarization. Journal of Integrative Medicine, 2022, 20(3): 274-280.
[6] Xin Wang, Wen-juan Song, Yi Ruan, Bing-chu Li, Can Lü, Nian Huang, Fan-fu Fang, Wei Gu. Core muscle functional strength training for reducing the risk of low-back pain in military recruits: An open-label randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 145-152.
[7] Peter Bablis, Henry Pollard, Anthony L. Rosner. Stress reduction via neuro-emotional technique to achieve the simultaneous resolution of chronic low back pain with multiple inflammatory and biobehavioural indicators: A randomized, double-blinded, placebo-controlled trial. Journal of Integrative Medicine, 2022, 20(2): 135-144.
[8] Victor Abou Nehmi Filho, Gilson Masahiro Murata, Ruan Carlos Macêdo de Moraes, Gabriely Cristina Alves Lima, Danielle Araujo de Miranda, Katrin Radloff, Raquel Galvão Figuerêdo Costa, Joyce de Cassia Rosa de Jesus, Jéssica Alves De Freitas, Nayara Izabel Viana, Ruan Pimenta, Katia Ramos Moreira Leite, José Pinhata Otoch, Ana Flávia Marçal Pessoa. A novel supplement with yeast β-glucan, prebiotic, minerals and Silybum marianum synergistically modulates metabolic and inflammatory pathways and improves steatosis in obese mice. Journal of Integrative Medicine, 2021, 19(5): 439-450.
[9] Meng-zhu Zhao, Chen Zhao, Shuang-shuang Tu, Xu-xu Wei, Hong-cai Shang. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials. Journal of Integrative Medicine, 2021, 19(4): 317-326.
[10] Na Zhi, Qian Mo, Shuo Yang, Yuan-xing Qin, Hao Chen, Zeng-guang Wu, Cai-hong Lan, Jun Zhang, Yin-long Li. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. Journal of Integrative Medicine, 2021, 19(2): 185-190.
[11] Si-chun Gu, Jie Zhou, Qing Ye, Can-xing Yuan. Pingchan granule for depressive symptoms in Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2021, 19(2): 120-128.
[12] Jie Wu, Shu-wei Duan, Hong-tao Yang, Yue-yi Deng, Wei Li, Ya-ni He, Zhao-hui Ni, Yong-li Zhan, Shan Lin, Zhi-yong Guo, Jun Zhu, Jing-ai Fang, Xu-sheng Liu, Li-hua Wang, Rong Wang, Nian-song Wang, Xiao-hong Cheng, Li-qun He, Ping Luo, Shi-ren Sun s, Ji-feng Sun, Ai-ping Yin, Geng-ru Jiang, Hong-yu Chen, Wen-hu Liu, Hong-li Lin, Meng Liang, Lu Ma, Ming Chen, Li-qun Song, Jian Chen, Qing Zhu, Chang-ying Xing, Yun Li, Ji-ning Gao, Rong-shan Li, Ying Li, Hao Zhang, Ying Lu, Qiao-ling Zhou, Jun-zhou Fu, Qiang He, Guang-yan Cai, Xiang-mei Chen. Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial. Journal of Integrative Medicine, 2021, 19(2): 111-119.
[13] Xian Wang, Xuan Yin, Xiu-tian Guo, Yan Wang, Wen-qi Jin, Ai-jun Mao, Lixing Lao, Zhang-jin Zhang, Jie Zhang, Shi-fen Xu. Effects of the pestle needle therapy, a type of acupoint stimulation, on post-hemorrhoidectomy pain: A randomized controlled trial. Journal of Integrative Medicine, 2020, 18(6): 492-498.
[14] Swatantra Kumar, Vimal K Maurya, Debadatta Nayak, Anil Khurana, Raj K Manchanda, Srinivasulu Gadugu, Madan LB Bhatt, Shailendra K Saxena. Calcarea carbonica treatment rescues lipopolysaccharide-induced inflammatory response in human mononuclear cells via downregulation of inducible cyclooxygenase pathway. Journal of Integrative Medicine, 2020, 18(5): 441-449.
[15] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
Full text



[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022